Volume 16, Number 9—September 2010
Research
Long-Term Health Risks for Children and Young Adults after Infective Gastroenteritis
Table 3
Type of sequelae | First-time hospitalizations |
Crude rate ratio, RR (95% CI) | Adjusted† rate ratio, RR (95% CI) | Adjusted AR, %‡ | Goodness of fit§ | ||||
---|---|---|---|---|---|---|---|---|---|
With history |
No history |
||||||||
No. | Rate | No. | Rate | ||||||
Any | 5,634 | 27.8 | 41,054 | 11.8 | 2.36 (2.28–2.41) | 1.64 (1.59–1.67) | 39 | 0.05 | |
Intragastrointestinal | 1,267 | 4.0 | 9,385 | 2.3 | 1.77 (1.67–1.88) | 1.52 (1.42–1.62) | 34 | 0.04 | |
Extragastrointestinal | 5,045 | 24.1 | 34,425 | 9.8 | 2.46 (2.39–2.54) | 1.63 (1.57–1.68) | 39 | 0.08 |
*Rates are per 100,000 person-years. RR, relative risk; CI, confidence interval; AR, attributable risk.
†Multivariate Cox regression estimating the adjusted rate ratio of first-time hospitalization for any, intragastrointestinal, and extragastrointestinal sequelae. Adjusted for gender, indigenous status, year of birth, age at exposure or proxy, singleton, weight at birth, hospital birth, mother’s region of birth, father’s region of birth, socioeconomic status, accessibility to services and previous hospitalization for comorbidity.
‡Proportion of first-time hospitalizations for sequelae where previous exposure to an enteric infection was a component cause.
§Pseudo R2. As explained by Hosmer and Lemeshow (20), a measure analogous to R2 would be useful as a measure of Cox regression model performance; however, although a pseudo R2 can be calculated the values obtained are often low because of the censored nature of the data even though the model is adequate. In our models the R2 values were 0.05, 0.04 and 0.08 for the 3 models (any, intragastrointestinal, and extragastrointestinal), respectively. The models generated were population-based descriptive models, which aimed to evaluate the average effect on survival to first-time hospitalization with the outcome of interest adjusted for known and measurable confounders, rather than predict the probability of survival for a specified individual. Thus, the most important assessment criteria for evaluating the appropriateness of a descriptive Cox regression model is that the proportional hazards assumption is not violated and the overall model is significant. In all of our models the proportional hazards assumption was tested and found not to be violated and the overall model significance was Prob > χ2 <0.00005.
References
- Harlem G. WHO report on infectious diseases: removing the obstacle to healthy development. Brunotland (Switzerland): World Health Organization; 1999.
- Hall GV, Kirk MD, Ashbolt R, Stafford R, Lalor K. Frequency of infectious gastrointestinal illness in Australia, 2002: regional, seasonal and demographic variation. Epidemiol Infect. 2006;134:111–8. DOIPubMedGoogle Scholar
- Heyworth JS, Glonek G, Maynard EJ, Baghurst PA, Finlay-Jones J. Consumption of untreated tank rainwater and gastroenteritis among young children in South Australia. Int J Epidemiol. 2006;35:1051–8. DOIPubMedGoogle Scholar
- Lindsay JA. Chronic sequelae of foodborne disease. Emerg Infect Dis. 1997;3:443–52. DOIPubMedGoogle Scholar
- Crushell E, Harty S, Sharif F, Bourke B. Enteric Campylobacter: purging its secrets? Pediatr Res. 2004;55:3–12. DOIPubMedGoogle Scholar
- Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis. 1995;20:1092–101. DOIPubMedGoogle Scholar
- Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis. 2008;14:143–8. DOIPubMedGoogle Scholar
- Baert D, De Man M, Oosterbosch L, Duyck MC, Van Der Spek P, Lepoutre L. Infectious gastroenteritis: are they all the same? Acta Clin Belg. 1995;50:269–73. PubMedGoogle Scholar
- Bunning VK, Lindsay JA, Archer DL. Chronic health effects of foodborne microbial disease. World Health Stat Q. 1997;50:51–6. PubMedGoogle Scholar
- Goudswaaed J, Sabbe L, Te Winkel W. Reactive arthritis as a complication of Campylobacter lari enteritis. J Infect. 1995;31:171–6. DOIPubMedGoogle Scholar
- Rees JH, Soudain SE, Gregson NE. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995;333:1374–9. DOIPubMedGoogle Scholar
- Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SN. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131:445–50. DOIPubMedGoogle Scholar
- Garg AX, Pope JE, Thiessen-Philbrook H, Clarke WF, Ouimet J. Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford). 2008;47:200–4. DOIPubMedGoogle Scholar
- Garg AX, Marshall J, Salvadori M, Thiessen-Philbrook HR, Macnab J, Suri RS, A gradient of acute gastroenteritis was characterized, to assess risk for long-term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol. 2006;59:421–8. DOIPubMedGoogle Scholar
- Australian Bureau of Statistics. Information paper, census of population and housing, socio-economic indexes for areas 2001. Canberra (Australia): The Bureau; 2003.
- Commonwealth Department of Health and Aged Care. Measuring remoteness: accessibility/remoteness index of Australia (ARIA) occasional papers: mew series number 14. Canberra (Australia): The Department; 2001.
- Holman CDJ, Preen DB, Baynham NJ, Finn JC, Semmens JB. A multipurpose Australian comorbidity scoring system performed better than the Charlson index. J Clin Epidemiol. 2005;58:1006–14. DOIPubMedGoogle Scholar
- Hosmer D, Lemeshow S. Survival analysis: regression modelling of time to event data. New York: John Wiley and Sons; 1999.
- Porter C, Tribble D, Aliaga P, Halvorson H, Riddle M. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135:781–6. DOIPubMedGoogle Scholar
- Kvien TK, Glennas A, Melby K, Gransfors K, Andrup O. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol. 1994;21:115–22. PubMedGoogle Scholar
- Kaldor J, Speed JR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed). 1984;288:1867–70. DOIPubMedGoogle Scholar
- Mishu Allos B. Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis. 1997;176(Suppl 2):S125–8. DOIPubMedGoogle Scholar
- Nachamkin I. Chronic effects of Campylobacter infection. Microbes Infect. 2002;4:399–403. DOIPubMedGoogle Scholar
- Neuwirth C, Francois C, Laurent N, Pechinot A. Myocarditis due to Salmonella virchow and sudden infant death. Lancet North Am Ed. 1999;354:1004.
- Holman C. Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23:453–9. DOIPubMedGoogle Scholar
- Hall G, Yohannes K, Raupach J, Becker N, Kirk M. Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin–producing Escherica coli infections, Australia. Emerg Infect Dis. 2008;14:1601–9. PubMedGoogle Scholar
- Thomas MK, Majowicz SE, Pollari F, Sockett PN. Burden of acute gastrointestinal illness in Canada, 1999–2007: interim summary of NSAGI activities. Can Commun Dis Rep. 2008;34:8–15. PubMedGoogle Scholar